Renewal of Provisional Consent to the Distribution of a New Medicine Pursuant to section 23 of the Medicines Act 1981, the Minister of Health hereby provisionally consents to the sale, supply or use in New Zealand of the new medicine set out in the Schedule hereto: Schedule Name and Strength Form Name and Address of Manufacturer Proprietary Name(if any) Interferon beta-1b 0.3 mg (9.6MIU); and diluent (sodium chloride 0.54% w/v) Injection, powder, vial and diluent, vial Chiron Corporation, Emeryville, California, United States of America Betaferon Note: This consent is valid for 2 years from 21 September 1997. Dated this 10th day of September 1997. G. R. BOYD, Chief Advisor, Regulation and Safety, pursuant to delegation given by the Minister of Health on 20 February 1997.